Concepedia

Mikhail S. Chesnokov

MS

Statistics

Publications

8

Citations

264

H-Index

8

Active since

2017

Affiliations

Lomonosov Moscow State University(Current)

Masonic Cancer Center

Massachusetts General Hospital

Hormel (United States)

Ministry of Health of the Russian Federation

Mikhail S. Chesnokov is an author at Lomonosov Moscow State University specializing in cancer therapeutics, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

2017–2024

8

Publications

8

Drug toxicity assessment: cell proliferation versus cell death

Elena V. Sazonova, Mikhail S. Chesnokov, Boris Zhivotovsky et al. · Cell Death Discovery · 2022 · 95 citations · Full text

Effect of method of deduplication on estimation of differential gene expression using RNA-seq

Anna V. Klepikova, Artem S. Kasianov, Mikhail S. Chesnokov et al. · PeerJ · 2017 · 44 citations · Full text

Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells

Mikhail S. Chesnokov, Marianna Halasi, Soheila Borhani et al. · Cell Death and Disease · 2021 · 31 citations · Full text

The MEK1/2 Pathway as a Therapeutic Target in High-Grade Serous Ovarian Carcinoma

Mikhail S. Chesnokov, Imran Khan, Yeonjung Park et al. · Cancers · 2021 · 28 citations · Full text

, , +10

FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML

Mikhail S. Chesnokov, Soheila Borhani, Marianna Halasi et al. · Frontiers in Oncology · 2021 · 27 citations · Full text

1–5 of 8